Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


26.05.2025

1 ACS Sens
1 Acta Obstet Gynecol Scand
1 Acta Oncol
1 Am J Transl Res
1 Anal Methods
1 Ann Surg Oncol
1 Aust N Z J Obstet Gynaecol
2 Biochem Biophys Res Commun
1 BMC Cancer
1 BMC Health Serv Res
2 BMC Infect Dis
1 BMC Public Health
1 BMC Res Notes
2 BMC Womens Health
4 Br J Gen Pract
1 Cancer Cytopathol
1 Cancer Med
1 Cell Biochem Biophys
1 Cell Death Dis
2 Cureus
3 Discov Oncol
1 Eur J Cancer Prev
1 Eur J Contracept Reprod Health Care
2 Eur J Obstet Gynecol Reprod Biol
1 Front Cell Infect Microbiol
4 Front Oncol
1 Front Public Health
1 Geburtshilfe Frauenheilkd
1 Gynecol Obstet Fertil Senol
1 Gynecol Oncol
1 Health Promot Int
1 Health Serv Insights
1 Hum Genomics
1 Int J Genomics
3 Int J Gynecol Cancer
1 Int J Radiat Oncol Biol Phys
2 Int J Surg
1 J Educ Health Promot
2 J Med Virol
1 J Natl Cancer Inst
1 J Radiat Res
1 JAMA Netw Open
1 Lasers Med Sci
1 Mediators Inflamm
1 Mol Biol Rep
1 Pathol Res Pract
1 Phytother Res
5 PLoS One
7 Sci Rep
1 Strahlenther Onkol
2 Stud Health Technol Inform
1 Transl Cancer Res
1 Tumour Virus Res
1 Turk Patoloji Derg
1 Virchows Arch
2 Virol J


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Sens

  1. LIU S, Yu T, Song L, Kalantar-Zadeh K, et al
    CRISPR/Cas on Microfluidic Paper-Based Analytical Devices for Point-of-Care Screening of Cervical Cancer.
    ACS Sens. 2025 May 19. doi: 10.1021/acssensors.5c00863.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  2. ERDAL JL, Serizawa RR, Rebolj M, Schroll JB, et al
    Outcomes associated with large loop excision of the cervical transformation zone in women 60-64 years of age: A population-based register study from Denmark.
    Acta Obstet Gynecol Scand. 2025;104:1112-1119.
    PubMed         Abstract available


    Acta Oncol

  3. ALSHAMRANI A, Chuter R, Aznar M, Hoskin P, et al
    Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancer.
    Acta Oncol. 2025;64:693-702.
    PubMed         Abstract available


    Am J Transl Res

  4. ZHOU L, Liu Y, Zhang Y, Hu F, et al
    ITGA5 promotes cervical cancer progression by regulating IMP3 recruitment of HK2 mRNA.
    Am J Transl Res. 2025;17:3031-3049.
    PubMed         Abstract available


    Anal Methods

  5. KOTAL H, Kalyani T, Lala A, R K, et al
    Development of a highly sensitive, label-free electrochemical immunosensor for p16INK4a detection: a step toward early cervical cancer diagnosis.
    Anal Methods. 2025 May 21. doi: 10.1039/d5ay00411.
    PubMed         Abstract available


    Ann Surg Oncol

  6. ZHANG C, Tian W, Zhou X, Li L, et al
    ASO Author Reflections: Laparoscopic Radical Hysterectomy has Equivalent Survival Outcomes Compared with Open Abdominal Radical Hysterectomy in Early-Stage Low-Risk Cervical Cancer.
    Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-024-16767.
    PubMed        


    Aust N Z J Obstet Gynaecol

  7. SANDEFORD J, Herbst U, Lum T, Anderson L, et al
    High-grade squamous intraepithelial lesions and adenocarcinoma in situ with a negative HPV cervical screening test. The role of HPV-ISH testing: A retrospective review.
    Aust N Z J Obstet Gynaecol. 2025;65:297-300.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  8. DING Q, Zhuang Y, Yang HY, Zhao XN, et al
    USP31 confers radio-resistance in cervical cancer cells via ferroptosis pathway by deubiquitinating and stabilizing GPX4.
    Biochem Biophys Res Commun. 2025;770:151990.
    PubMed         Abstract available

  9. YU L, Han W, Zhang J, Liu G, et al
    Repurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer: Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis.
    Biochem Biophys Res Commun. 2025;771:152040.
    PubMed         Abstract available


    BMC Cancer

  10. LI K, Huang F, Zhang T, Yang F, et al
    HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study.
    BMC Cancer. 2025;25:885.
    PubMed         Abstract available


    BMC Health Serv Res

  11. FAYEHUN O, Apenteng P, Umar UA, Adebayo KO, et al
    Diagnosis of cancer in the South and North of Nigeria: duration and causes of delay.
    BMC Health Serv Res. 2025;25:738.
    PubMed         Abstract available


    BMC Infect Dis

  12. PENG Y, Tang Q, Wu S, Zhao C, et al
    Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis.
    BMC Infect Dis. 2025;25:708.
    PubMed         Abstract available

  13. CHEN H, Wang Q, Kang M, Huang W, et al
    HPV-associated squamous cell carcinoma and adenocarcinoma in distinct cervical sites: a case report.
    BMC Infect Dis. 2025;25:732.
    PubMed         Abstract available


    BMC Public Health

  14. GAO D, Wang X, Juan J, Pei Z, et al
    Association between knowledge of cervical cancer prevention and screening behaviors among women aged 20 to 49 years: a cross-sectional study in six provinces, China.
    BMC Public Health. 2025;25:1821.
    PubMed         Abstract available


    BMC Res Notes

  15. HASHEMI SMA, Alipour AH, Emamifar S, Farhadi A, et al
    Epstein-Barr virus nuclear antigen 1 (EBNA1) increases the expression levels of MDM2 and MDM4 genes in HeLa cells: a review on MDM2 and MDM4 roles in cancer.
    BMC Res Notes. 2025;18:221.
    PubMed         Abstract available


    BMC Womens Health

  16. FATHI PS, Sofian M, Almasi-Hashiani A, Sadat Larijani M, et al
    Insufficient knowledge of Human Papillomavirus among reproductive-aged women from Arak, Iran.
    BMC Womens Health. 2025;25:238.
    PubMed         Abstract available

  17. AKTARY ML, Bartel R, James A, Kima J, et al
    Cervical and breast cancer screening outcomes among Metis people in Alberta, Canada.
    BMC Womens Health. 2025;25:246.
    PubMed         Abstract available


    Br J Gen Pract

  18. PETTITT C, Ali A
    Trauma-informed practice for promotion of cervical cancer screening: an exploration of factors influencing engagement with cervical cancer screening.
    Br J Gen Pract. 2025;75.
    PubMed         Abstract available

  19. DI MARTINO E, Bradley S, Khan T, Foy R, et al
    Improving cervical cancer screening uptake in general practice: a feedback intervention feasibility study.
    Br J Gen Pract. 2025;75.
    PubMed         Abstract available

  20. MARTIN K, McNamara P
    Understanding the barriers contributing to 'missingness' of patients from deep-end practices within the cervical smear screening programme.
    Br J Gen Pract. 2025;75.
    PubMed         Abstract available

  21. BASKARAN N, Pader A, Momin F, Khan R, et al
    Exploring the health inequalities and potential solutions to cervical screening uptake in primary care.
    Br J Gen Pract. 2025;75.
    PubMed         Abstract available


    Cancer Cytopathol

  22. RIVERA ROLON MDM, Gustafson E, Cole R, Matos J, et al
    Implementing 100% quality control in a cervical cytology workflow using whole slide images and artificial intelligence provided by the Techcyte SureView System.
    Cancer Cytopathol. 2025;133:e70019.
    PubMed         Abstract available


    Cancer Med

  23. MUMPER M, Nolen L, Herget KA, Codden RR, et al
    Changes in Breast and Cervical Cancer Incidence by Stage at Diagnosis During the COVID-19 Pandemic in Utah.
    Cancer Med. 2025;14:e70952.
    PubMed         Abstract available


    Cell Biochem Biophys

  24. KEVAT S, Mistry A, Oza N, Majmudar M, et al
    Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights into Breast, Cervical and Lung Cancer.
    Cell Biochem Biophys. 2025;83:1521-1535.
    PubMed         Abstract available


    Cell Death Dis

  25. YE Z, Zhu L, Wei Y, Lin A, et al
    USP25-driven KIFC1 regulates MYCBP expression and promotes the progression of cervical cancer.
    Cell Death Dis. 2025;16:390.
    PubMed         Abstract available


    Cureus

  26. TOGAMI S, Fufuzono N, Fukuda M, Kobayashi H, et al
    Indocyanine Green and Radioisotope Tracers for Sentinel Lymph Node Mapping in Early-Stage Cervical Cancer: A Prospective Comparative Study.
    Cureus. 2025;17:e82644.
    PubMed         Abstract available

  27. NDUKWE MI, Pohankova D, Halada P, Laco J, et al
    First-Trimester Radical Hysterectomy for Bulky Cervical Cancer: A Case Report on Oncologic and Reproductive Considerations.
    Cureus. 2025;17:e82486.
    PubMed         Abstract available


    Discov Oncol

  28. ZHU Y, Shi X, Zhang S, Cui H, et al
    Prognostic value of circ_0000043/miR-590-5p in cervical cancer and regulation of tumor progression.
    Discov Oncol. 2025;16:879.
    PubMed         Abstract available

  29. FRIDLJUNG J, Bergengren L, Ryen L, Lillsunde Larsson G, et al
    Modelling the cost-effectiveness of cervical cancer screening with HPV self-sampling and molecular triage for women aged 60-69 years.
    Discov Oncol. 2025;16:805.
    PubMed         Abstract available

  30. LIU Y, Pan X, Zhang X, Tan B, et al
    Novel marker genes and small molecule drugs for radiotherapy resistance in cervical cancer identified based on single-cell multi-omics analysis.
    Discov Oncol. 2025;16:823.
    PubMed         Abstract available


    Eur J Cancer Prev

  31. FERNANDES A, Lunet N
    Human papillomavirus vaccination, cervical cancer screening, and acceptability of self-sampling: a cross-sectional study in vulnerable women.
    Eur J Cancer Prev. 2025 May 19. doi: 10.1097/CEJ.0000000000000975.
    PubMed         Abstract available


    Eur J Contracept Reprod Health Care

  32. CORREA CM, Zeferino LC, Bahamondes L
    Association of intrauterine device use and risk of abnormal cervical cytology.
    Eur J Contracept Reprod Health Care. 2025;30:87-92.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  33. PALUMBO M, Lavitola G, Di Filippo C, Foreste V, et al
    Impact of Human papillomavirus 9-valent vaccine on viral clearance after surgical treatment: A single-center retrospective observational study.
    Eur J Obstet Gynecol Reprod Biol. 2025;310:113994.
    PubMed         Abstract available

  34. ZHU Y, Zhao C, Liu H, Li Y, et al
    Can contrast-enhanced ultrasound differentiate cervical lesions?
    Eur J Obstet Gynecol Reprod Biol. 2025;310:113998.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  35. ZHAI Q, Zhao L, Wang M, Li L, et al
    Integrated analysis of microbiome and metabolome reveals insights into cervical neoplasia aggravation in a Chinese cohort.
    Front Cell Infect Microbiol. 2025;15:1556153.
    PubMed         Abstract available


    Front Oncol

  36. SHI J, Wang L, Zhou M, Ge S, et al
    Harnessing unsupervised machine learning with [(18)F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Front Oncol. 2025;15:1486654.
    PubMed         Abstract available

  37. JAASKELAINEN E, Karkkainen H, Palmgren JE, Haataja M, et al
    Implementing treatment according to the guidelines is of paramount importance in locally advanced cervical cancer: a real-world study.
    Front Oncol. 2025;15:1562067.
    PubMed         Abstract available

  38. BI S, Zhou J, Xu M, Dai Z, et al
    Reevaluating BED in cervical cancer HDR brachytherapy: source decay and tissue-specific repair significantly impact radiobiological dose.
    Front Oncol. 2025;15:1407606.
    PubMed         Abstract available

  39. WU F, Lu Z, Que J, Ma S, et al
    The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.
    Front Oncol. 2025;15:1514425.
    PubMed         Abstract available


    Front Public Health

  40. ROSTAMI VARNOUSFADERANI M, Khoshnazar Z, Zeratie H, Hosseini Koukamari P, et al
    Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule on immunogenicity and cervical cancer prevention.
    Front Public Health. 2025;13:1544220.
    PubMed         Abstract available


    Geburtshilfe Frauenheilkd

  41. DENSCHLAG D, Czogalla B, Heitz F, Kerkmann M, et al
    Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study: A Quality Assurance Initiative of the AGO-Study Group and AGO-OK Uter
    Geburtshilfe Frauenheilkd. 2025;85:520-532.
    PubMed         Abstract available


    Gynecol Obstet Fertil Senol

  42. BENARD A, Alipour S, Mauny F, Grillot M, et al
    [Optimization of cervical cancer screening in France: a prospective multicenter clinical study].
    Gynecol Obstet Fertil Senol. 2025 May 14:S2468-7189(25)00121.
    PubMed        


    Gynecol Oncol

  43. GU J, Zheng W, Li F, Luo C, et al
    Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node metastasis which is comparable to stage IIIC.
    Gynecol Oncol. 2025;198:17-24.
    PubMed         Abstract available


    Health Promot Int

  44. DRYSDALE K, Creagh NS, Nightingale C, Whop LJ, et al
    Beyond words: operationalizing inclusive language in Australian cervical screening health promotion policy.
    Health Promot Int. 2025;40:daaf058.
    PubMed         Abstract available


    Health Serv Insights

  45. AKUOKU V, Ashaley MD
    Knowledge and Prevalence of Cervical Cancer Screening Among Women Receiving Prenatal Care in Accra, Ghana: A Cross-Sectional Study.
    Health Serv Insights. 2025;18:11786329251337851.
    PubMed         Abstract available


    Hum Genomics

  46. LIEN JY, Hii LA, Su PH, Chen LY, et al
    Exploring potential methylation markers for ovarian cancer from cervical scraping samples.
    Hum Genomics. 2025;19:56.
    PubMed         Abstract available


    Int J Genomics

  47. SHEN X, Sun H, Zhang S
    Comprehensive Single-Cell RNA Sequencing Analysis of Cervical Cancer: Insights Into Tumor Microenvironment and Gene Expression Dynamics.
    Int J Genomics. 2025;2025:5027347.
    PubMed         Abstract available


    Int J Gynecol Cancer

  48. ZEEVI G, Eitan R
    The art of prevention: merging creativity and medicine to transform cervical cancer awareness.
    Int J Gynecol Cancer. 2025;35:101909.
    PubMed        

  49. NAVARRO AS, Ricotta G, Gauroy E, Martinez A, et al
    Urinary reconstruction using enterocystoplasty after partial cystectomy in surgical recurrence of cervical cancer.
    Int J Gynecol Cancer. 2025;35:101813.
    PubMed        

  50. FALLAH PN, Salcedo MP, Nhacule E, Utui Y, et al
    A randomized clinical trial to assess the effectiveness of thermal ablation versus loop electrosurgical excision procedure for cervical cancer risk reduction in women living with HIV in Mozambique.
    Int J Gynecol Cancer. 2025 Apr 26:101905. doi: 10.1016/j.ijgc.2025.101905.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  51. AHMED KA, Quick AM, Chon HS, Chern JY, et al
    Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results from a Phase II Multi-Institutional Study.
    Int J Radiat Oncol Biol Phys. 2025 May 14:S0360-3016(25)00446.
    PubMed         Abstract available


    Int J Surg

  52. XIAO J, Niu R, Zhao F
    Single-cell and spatial transcriptome analysis revealed cellular heterogeneity of glycosyltransferases in cervical cancer, and identified GALNT3-negative epithelial cells as a protective factor: a retrospective cohort study based on public database.
    Int J Surg. 2025 May 16. doi: 10.1097/JS9.0000000000002520.
    PubMed         Abstract available

  53. YANG X, Chen S, Li Y, Peng J, et al
    Laparoscopic radical hysterectomy-karez technique for stage IB3 and IIA2 cervical cancer: a multicenter retrospective cohort study.
    Int J Surg. 2025 May 16. doi: 10.1097/JS9.0000000000002522.
    PubMed         Abstract available


    J Educ Health Promot

  54. AGRAWAL S, Padhan S, Panneerselvam S, Ramasamy S, et al
    Nurses at the forefront in cervical cancer: HPV vaccine promotion to combat the deadly disease in India.
    J Educ Health Promot. 2025;14:153.
    PubMed         Abstract available


    J Med Virol

  55. HUANG Y, Liang F, Huang J, Jiang H, et al
    Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki-67, Individually and in Combination.
    J Med Virol. 2025;97:e70405.
    PubMed         Abstract available

  56. YE C, Liu Y, Huang H, Chen R, et al
    Risk-Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real-World Study.
    J Med Virol. 2025;97:e70404.
    PubMed         Abstract available


    J Natl Cancer Inst

  57. VAN DEN BORST E, Bell M, Op De Beeck K, Van Camp G, et al
    Lineages and sublineages of high-risk HPV types associated with cervical cancer and precancer: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2025 May 16:djaf118. doi: 10.1093.
    PubMed         Abstract available


    J Radiat Res

  58. TAKATSU J, Murakami N, Okonogi N, Inoue T, et al
    Optimizing dwell time weight for interstitial needles in intracavitary/interstitial hybrid brachytherapy: balancing tumor coverage with organ sparing using the inverse planning technique.
    J Radiat Res. 2025;66:296-305.
    PubMed         Abstract available


    JAMA Netw Open

  59. FITZPATRICK MB, Behrens CM, Hibler K, Parsons C, et al
    Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use: A Nonrandomized Clinical Trial.
    JAMA Netw Open. 2025;8:e2511081.
    PubMed         Abstract available


    Lasers Med Sci

  60. MOHAMED SHAIE K, Abdulkadir Ali M, Andrea M, Yan H, et al
    The role of photodynamic therapy in treating LSIL in women with high-risk HPV: a literature review.
    Lasers Med Sci. 2025;40:237.
    PubMed         Abstract available


    Mediators Inflamm

  61. LIU Y, Zhao G, Kong Y, Zhou F, et al
    Detection of the Prognostic Gene CYB5D2 in Cervical Squamous Epithelial Lesions.
    Mediators Inflamm. 2025;2025:2360364.
    PubMed         Abstract available


    Mol Biol Rep

  62. ASOUDEH-FARD A, Sis FF, Rahmani B, Kamranjam M, et al
    Inhibitory effects of tetraselmis algae extract on cervical cancer cell proliferation: a molecular and cellular approach.
    Mol Biol Rep. 2025;52:473.
    PubMed         Abstract available


    Pathol Res Pract

  63. TEH TRD, de Leon VNO, Tantengco OAG
    Role of extracellular vesicles in the pathophysiology, diagnosis, and prognosis of gynecological cancers.
    Pathol Res Pract. 2025;270:155987.
    PubMed         Abstract available


    Phytother Res

  64. HOSSEINI MS, Sadeqi A, Heidari Z, Boozari M, et al
    A Comprehensive Review of Biologically Active Natural Products on Human Papillomavirus (HPV) at a Glance.
    Phytother Res. 2025;39:2262-2290.
    PubMed         Abstract available


    PLoS One

  65. NOREEN K, Khalid SN, Javaid M, Khan SA, et al
    Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
    PLoS One. 2025;20:e0323826.
    PubMed         Abstract available

  66. ZARGARAN H, Ghaemi A, Shenagari M, Samadi M, et al
    Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.
    PLoS One. 2025;20:e0312979.
    PubMed         Abstract available

  67. DANIELS J, Kyei KA, Frimpong-Boateng PD, Nyantakyi AY, et al
    Sexual function outcomes in prostate and cervical cancer patients treated with radiotherapy in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2025;20:e0324662.
    PubMed         Abstract available

  68. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Correction: Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2025;20:e0324971.
    PubMed         Abstract available

  69. GOVINDSAMY K, Noll S, Blose N, Amponsah-Dacosta E, et al
    Effectiveness of integrating cervical cancer prevention strategies into HIV care programmes: A mixed-methods systematic review protocol.
    PLoS One. 2025;20:e0306496.
    PubMed         Abstract available


    Sci Rep

  70. SHEN L, Zhou L, Xi X, Hou S, et al
    Retrospective analysis of 274 cases suspected vaginal intraepithelial neoplasia.
    Sci Rep. 2025;15:17506.
    PubMed         Abstract available

  71. CAO L, Abudureheman W, Shen G, Ouyang Y, et al
    LncRNA NEAT1 regulation of the miR-101-3p/RAC1 axis affects cervical cancer aerobic glycolysis and progression.
    Sci Rep. 2025;15:17436.
    PubMed         Abstract available

  72. BASIR FA, Blyuss KB, Raezah AA, Rahman B, et al
    Mathematical modelling of the role of Langerhans cells in the dynamics of HPV infection.
    Sci Rep. 2025;15:17505.
    PubMed         Abstract available

  73. CHEN X, Xu H, Zhao L, Jiang H, et al
    The role of PAX1 and JAM3 methylation in predicting the pathological upgrading of cervical intraepithelial neoplasia before conization.
    Sci Rep. 2025;15:17684.
    PubMed         Abstract available

  74. FAN X, Liang X, Guo Y, Jin G, et al
    125I inhibits the progression of cervical cancer by upregulating the HSF1/PU.1/SYK signaling pathway and consequently enhancing the apoptotic response mediated by ROS/USP7/P53.
    Sci Rep. 2025;15:17690.
    PubMed         Abstract available

  75. ZHANG B, Zhao W, Huang C, Lan Q, et al
    Optimized segmentation of overlapping cervical cells based on Mask2Former and denoising.
    Sci Rep. 2025;15:17715.
    PubMed         Abstract available

  76. ZHU X, Zhang L, Yu X, Yan P, et al
    Elucidating the tumor microenvironment interactions in breast, cervical, and ovarian cancer through single-cell RNA sequencing.
    Sci Rep. 2025;15:17846.
    PubMed         Abstract available


    Strahlenther Onkol

  77. NEU M, Wohrl CM, Walter R, Balagiannis N, et al
    Multimodal chemoradiotherapy including interstitial brachytherapy enhances outcomes in FIGO stage IVA cervical cancer: a focus on tumor control and quality of life.
    Strahlenther Onkol. 2025 May 21. doi: 10.1007/s00066-025-02407.
    PubMed         Abstract available


    Stud Health Technol Inform

  78. SKARGA-BANDUROVA I, Sharifnia G, Biloborodova T
    Bias Detection in Histology Images Using Explainable AI and Image Darkness Assessment.
    Stud Health Technol Inform. 2025;327:203-207.
    PubMed         Abstract available

  79. ELWES M, Koppolu BP, Lapuz C, Tacey M, et al
    From Normal to Optimal: Investigating Metabolic and Inflammatory Parameters as Predictors of Survival in Locally Advanced Cervical Cancer.
    Stud Health Technol Inform. 2025;327:572-576.
    PubMed         Abstract available


    Transl Cancer Res

  80. LI Y, Hong Y, Shen H, Zhou J, et al
    FXR activation suppresses NF-kappaB signaling, proliferation and migration in cervical cancer cells.
    Transl Cancer Res. 2025;14:2440-2456.
    PubMed         Abstract available


    Tumour Virus Res

  81. OUYANG Y, Abuduxikuer G, Abulimiti T, Abudurexiti G, et al
    Clinical performance of the SureX PCR HPV test versus hybrid capture assays (DH2/careHPV) in primary cervical cancer screening.
    Tumour Virus Res. 2025;19:200319.
    PubMed         Abstract available


    Turk Patoloji Derg

  82. AKCA Y, Uzun E, Erkilic S
    Comprehensive Evaluation of the Utility of Cell Block Use in ThinPrep Liquid-Based Cervical Specimens.
    Turk Patoloji Derg. 2025;1.
    PubMed         Abstract available


    Virchows Arch

  83. LIU K, Shi H, Gao L, Ye L, et al
    Endocervical adenocarcinoma with a micropapillary component: a clinicopathologic analysis in the setting of current WHO classification.
    Virchows Arch. 2025;486:1011-1021.
    PubMed         Abstract available


    Virol J

  84. WANG Y, Hou H, Dong G, Zhang H, et al
    Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015-2023.
    Virol J. 2025;22:157.
    PubMed         Abstract available

  85. KERMANSHAHI AZ, Ebrahimi F, Taherpoor A, Eslami N, et al
    HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy.
    Virol J. 2025;22:156.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.